Company intelligence / Profile preview

Fractal Therapeutics

Cambridge, Massachusetts, United Statesfractaltx.com ↗

Ownership: Private
Development stage: Other

Overview

Fractal Therapeutics specialized in providing mathematical modeling and simulation to optimize preclinical and early clinical drug development. They supported clients with IND-enabling studies and regulatory documentation but did not develop their own therapeutic pipeline.

Modalities: Small moleculeBiologicAntibody
Industry: Contract Research Organization

Partnerships

Early-stage biotechs and academic groups as clients

Beyond the preview

Go deeper on Fractal Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fractal Therapeutics.

Explore the full profile